Identification of a Dominant Epitope of Glutamic Acid Decarboxylase (GAD-65) Recognized by Autoantibodies in Stiff-Man Syndrome

Journal of Experimental Medicine - United States
doi 10.1084/jem.178.6.2097
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus Lactis Reverses Diabetes in Recent-Onset NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Identification and Modulation of a Naturally Processed T Cell Epitope From the Diabetes-Associated Autoantigen Human Glutamic Acid Decarboxylase 65 (hGAD65)

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

A New Microassay Method for L-Glutamic Acid Decarboxylase (Gad) Activity

The Japanese Journal of Pharmacology
1975English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

The Role of Anti-Glutamic Acid Decarboxylase Autoantibodies in Mood Disorders

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2015English

Detection of Autoantibodies Against Reactive Oxygen Species Modified Glutamic Acid Decarboxylase-65 in Type 1 Diabetes Associated Complications

BMC Immunology
Immunology
2011English

Region-Specific Regulation of Glutamic Acid Decarboxylase (GAD) mRNA Expression in Central Stress Circuits

Journal of Neuroscience
Neuroscience
1998English

Anti–Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome

Archives of Neurology
2004English

Epilepsy in Mice Deficient in the 65-kDa Isoform of Glutamic Acid Decarboxylase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy